130 related articles for article (PubMed ID: 33646419)
1. Early response assessment after CyberKnife stereotactic radiosurgery for symptomatic vertebral hemangioma by quantitative parameters from dynamic contrast-enhanced MRI.
Chen Y; Zhang E; Wang Q; Yuan H; Zhuang H; Lang N
Eur Spine J; 2021 Oct; 30(10):2867-2873. PubMed ID: 33646419
[TBL] [Abstract][Full Text] [Related]
2. Use of dynamic contrast-enhanced MRI for the early assessment of outcome of CyberKnife stereotactic radiosurgery for patients with spinal metastases.
Chen Y; Zhang E; Wang Q; Yuan H; Zhuang H; Lang N
Clin Radiol; 2021 Nov; 76(11):864.e1-864.e6. PubMed ID: 34404514
[TBL] [Abstract][Full Text] [Related]
3. CyberKnife stereotactic radiosurgery for the treatment of symptomatic vertebral hemangiomas: a single-institution experience.
Zhang M; Chen YR; Chang SD; Veeravagu A
Neurosurg Focus; 2017 Jan; 42(1):E13. PubMed ID: 28041316
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.
Chidambaram S; Pannullo SC; Roytman M; Pisapia DJ; Liechty B; Magge RS; Ramakrishna R; Stieg PE; Schwartz TH; Ivanidze J
Neurosurg Focus; 2019 Jun; 46(6):E10. PubMed ID: 31153141
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
7. Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot Study.
Shah AD; Shridhar Konar A; Paudyal R; Oh JH; LoCastro E; Nuñez DA; Swinburne N; Vachha B; Ulaner GA; Young RJ; Holodny AI; Beal K; Shukla-Dave A; Hatzoglou V
J Neuroimaging; 2021 Mar; 31(2):317-323. PubMed ID: 33370467
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging for evaluating early response to radiosurgery in patients with vestibular schwannoma.
Özer H; Yazol M; Erdoğan N; Emmez ÖH; Kurt G; Öner AY
Jpn J Radiol; 2022 Jul; 40(7):678-688. PubMed ID: 35038116
[TBL] [Abstract][Full Text] [Related]
9. DCE-MRI Quantitative Parameters as Predictors of Treatment Response in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Underwent CCRT.
Liu B; Sun Z; Ma WL; Ren J; Zhang GW; Wei MQ; Hou WH; Hou BX; Wei LC; Huan Y; Zheng MW
Front Oncol; 2020; 10():585738. PubMed ID: 33194734
[TBL] [Abstract][Full Text] [Related]
10. The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy.
Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Liu P; Li X; Chen Z; Long X; Pang Q; Deng S; Gu J
Cancer Manag Res; 2021; 13():6065-6078. PubMed ID: 34377025
[TBL] [Abstract][Full Text] [Related]
11. Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.
Di N; Cheng W; Jiang X; Liu X; Zhou J; Xie Q; Chu Z; Chen H; Wang B
J Neuroradiol; 2019 May; 46(3):186-192. PubMed ID: 29752976
[TBL] [Abstract][Full Text] [Related]
12. Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients.
Huang YS; Chen JL; Hsu FM; Huang JY; Ko WC; Chen YC; Jaw FS; Yen RF; Chang YC
J Magn Reson Imaging; 2018 Jan; 47(1):191-199. PubMed ID: 28480541
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-Weighted and Dynamic Contrast-Enhanced MRI Derived Imaging Metrics for Stereotactic Body Radiotherapy of Pancreatic Ductal Adenocarcinoma: Preliminary Findings.
Kinh Do R; Reyngold M; Paudyal R; Oh JH; Konar AS; LoCastro E; Goodman KA; Shukla-Dave A
Tomography; 2020 Jun; 6(2):261-271. PubMed ID: 32548304
[TBL] [Abstract][Full Text] [Related]
14. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
16. Assessment of irradiated brain metastases using dynamic contrast-enhanced magnetic resonance imaging.
Almeida-Freitas DB; Pinho MC; Otaduy MC; Braga HF; Meira-Freitas D; da Costa Leite C
Neuroradiology; 2014 Jun; 56(6):437-43. PubMed ID: 24652530
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance perfusion volumetrics can differentiate tuberculosis of the spine and vertebral malignancy.
Verma M; Sood S; Singh B; Thakur M; Sharma S
Acta Radiol; 2022 Nov; 63(11):1504-1512. PubMed ID: 34806421
[TBL] [Abstract][Full Text] [Related]
18. A Pilot Study Evaluating the Use of Dynamic Contrast-Enhanced Perfusion MRI to Predict Local Recurrence After Radiosurgery on Spinal Metastases.
Kumar KA; Peck KK; Karimi S; Lis E; Holodny AI; Bilsky MH; Yamada Y
Technol Cancer Res Treat; 2017 Dec; 16(6):857-865. PubMed ID: 28449626
[TBL] [Abstract][Full Text] [Related]
19. [Feasibility study of dynamic contrast enhanced magnetic resonance imaging qualitative diagnosis of musculoskeletal tumors].
Zhang J; Zuo PL; Cheng KB; Yu AH; Cheng XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 48(2):287-91. PubMed ID: 27080283
[TBL] [Abstract][Full Text] [Related]
20. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
